A combination of strategies based on metabolic checkpoint blockade, growth factor inhibition (e.g., via ligand traps [23,24]), and multilevel suppression of mTOR [25,26] appears to have great potential for cancer treatment by simultaneously reprogramming cancer cell metabolism, enhancing the immune response and inhibiting cancer cell proliferation and survival. Here, MTOR is linked to cancer.